Drug-Device Combination
BioQ Pharma
Proprietary invenious™ infusion platform. Four approved products with 44 global marketing authorizations and 50+ US patents across pain, anesthesia and oncology.
Illustrative pipeline examples across diagnostics, devices, drug-device combinations, neurotechnology, and aesthetic laser systems.
Drug-Device Combination
Proprietary invenious™ infusion platform. Four approved products with 44 global marketing authorizations and 50+ US patents across pain, anesthesia and oncology.
AI-Enabled Diagnostics
Smart Scope® CX detects cervical cancer in under five minutes, offline-capable. Pre-IPO. Pipeline includes oral and breast cancer screening.
Neurotechnology
Axon — a clinically validated BCI headset for chronic pain. 30-minute at-home sessions with remote monitoring. Hardware plus subscription model.
AI Cardiovascular Diagnostics
First non-invasive point-of-care cardiovascular test. AI cloud results in ~30 minutes. No radiation, no capital equipment, per-scan billing.
Therapeutic Devices
FDA-cleared LED hair regrowth platform. 65+ patents and ~75% gross margins. Channels across physicians, affiliates and DTC.
Cancer Diagnostics
OraFusion — chairside oral cancer risk assessment combining saliva biomarkers, clinical factors and AI. Recurring consumables business model.
Aesthetic Laser Technology
Botticelli™ Athena and Primavera — multi-wavelength skin rejuvenation platforms. Five awarded patents. Razor / razor-blade revenue model.
Neurotechnology · Devices
Non-invasive EEG-based chronic pain treatment. Hardware plus SaaS subscription, addressing a large global market without drugs.
Diagnostics
Non-invasive neonatal jaundice diagnostic device. Quick and endorsed by the APA. Large addressable market in GCC, MENA and India.